Changes in antimüllerian hormone levels in early pregnancy are associated with preterm birth

Fertility and Sterility

Volumn 104, Issue 2, 2015, Pages 347-355.e3

  Stegmann, Barbara J ^a   Santillan, Mark ^b   Leader, Benjamin ^c   Smith, Elaine ^a   Santillan, Donna ^b  

^a Department of Epidemiology   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Clinical Research Division   (United States)

Author keywords

Antim llerian hormone (AMH); maternal serum alpha fetoprotein (MSAFP); ovarian biomarkers; placental biomarkers; preterm birth

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; MUELLERIAN INHIBITING FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROGESTERONE; BIOLOGICAL MARKER;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ANEUPLOIDY; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FETOPLACENTAL UNIT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; MATERNAL SMOKING; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; UNITED STATES; WEIGHT CHANGE; BLOOD; CASE CONTROL STUDY; PREMATURE BIRTH; PRENATAL DIAGNOSIS; PROCEDURES; TRENDS; YOUNG ADULT;

ADULT; ANTI-MULLERIAN HORMONE; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; PREGNANCY; PREMATURE BIRTH; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84938285480     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.04.044     Document Type: Article

References (41)

1. H. Blencowe, S. Cousens, M.Z. Oestergaard, D. Chou, A.B. Moller, R. Narwal, and et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications Lancet 379 2012 2162 2172
2. World Health Organization 9th ed. Manual of the international statistical classification of diseases, injuries, and causes of death Vol. 1 1977 World Health Organization Geneva
3. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Epidemiology and causes of preterm birth Lancet 371 2008 75 84
4. M.J. Stout, K.R. Goetzinger, M.G. Tuuli, A.G. Cahill, G.A. Macones, and A.O. Odibo First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth Placenta 34 2013 14 19
5. Seattle Children's. Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) [Web site]. Available at: www.gapps.org. Accessed March 16, 2014.
6. N.H. Morken, K. Kallen, and B. Jacobsson Predicting risk of spontaneous preterm delivery in women with a singleton pregnancy Paediatr Perinat Epidemiol 28 2014 11 22
7. A. Metcalfe, S. Langlois, J. Macfarlane, H. Vallance, and K.S. Joseph Prediction of obstetrical risk using maternal serum markers and clinical risk factors Prenat Diagn 34 2014 172 179
8. N. Sananes, N. Meyer, A. Gaudineau, G. Aissi, E. Boudier, G. Fritz, and et al. Prediction of spontaneous preterm delivery in the first trimester of pregnancy Eur J Obstet Gynecol Reprod Biol 171 2013 18 22
9. W. Yuan, L. Chen, and A.L. Bernal Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis Eur J Obstet Gynecol Reprod Biol 145 2009 57 64
10. E.R. Norwitz Defective implantation and placentation: laying the blueprint for pregnancy complications Reprod Biomed Online 13 2007 591 599
11. M.S. Kramer, A. Papageorghiou, J. Culhane, Z. Bhutta, R.L. Goldenberg, M. Gravett, and et al. Challenges in defining and classifying the preterm birth syndrome Am J Obstet Gynecol 206 2012 108 112
12. I. Brosens, I. Derwig, J. Brosens, L. Fusi, G. Benagiano, and R. Pijnenborg The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod 25 2010 569 574
13. G. Androutsopoulos, P. Gkogkos, and G. Decavalas Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome Int J Endocrinol Metab 11 2013 102 106
14. S. Muttukrishna, R.A. North, J. Morris, J.C. Schellenberg, R.S. Taylor, J. Asselin, and et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia Hum Reprod 15 2000 1640 1645
15. S. Chandra, H. Scott, L. Dodds, C. Watts, C. Blight, and M. Van Den Hof Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes Am J Obstet Gynecol 189 2003 775 781
16. Y. Yaron, M. Cherry, R.L. Kramer, J.E. O'Brien, M. Hallak, M.P. Johnson, and et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome Am J Obstet Gynecol 181 1999 968 974
17. A.I. Csapo, and M. Pulkkinen Indispensability of the human corpus luteum in the maintenance of early pregnancy: luteectomy evidence Obstet Gynecol Surv 33 1978 69 81
18. D.D. Baird, C.R. Weinberg, D.R. McConnaughey, and A.J. Wilcox Rescue of the corpus luteum in human pregnancy Biol Reprod 68 2003 448 456
19. P.K. Siiteri, and D.P. Stites Immunologic and endocrine interrelationships in pregnancy Biol Reprod 26 1982 1 14
20. A.L. Durlinger, J.A. Visser, and A.P. Themmen Regulation of ovarian function: the role of anti-müllerian hormone Reproduction 124 2002 601 609
21. J.A. Visser, and A.P. Themmen Anti-müllerian hormone and folliculogenesis Mol Cell Endocrinol 234 2005 81 86
22. I.A. Van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, F.H. de Jong, and et al. Serum anti-müllerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
23. A. La Marca, S. Giulini, R. Orvieto, V. De Leo, and A. Volpe Anti-müllerian hormone concentrations in maternal serum during pregnancy Hum Reprod 20 2005 1569 1572
24. S.M. Nelson, F. Stewart, R. Fleming, and D.J. Freeman Longitudinal assessment of antimüllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin Fertil Steril 93 2010 1356 1358
25. H.W. Li, P.W. Hui, M.H. Tang, E.T. Lau, W.S. Yeung, P.C. Ho, and et al. Maternal serum anti-müllerian hormone level is not superior to chronological age in predicting Down syndrome pregnancies Prenat Diagn 30 2010 320 324
26. J.S. Davis, and B.R. Rueda The corpus luteum: an ovarian structure with maternal instincts and suicidal tendencies Front Biosci 7 2002 d1949 d1978
27. A. Weghofer, W. Dietrich, I. Ortner, C. Bieglmayer, D. Barad, and N. Gleicher Anti-müllerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery Reprod Biol Endocrinol 9 2011 98
28. A. Koninger, A. Kauth, B. Schmidt, M. Schmidt, G. Yerlikaya, S. Kasimir-Bauer, and et al. Anti-müllerian-hormone levels during pregnancy and postpartum Reprod Biol Endocrinol 11 2013 60
29. J.A. Martin, B.E. Hamilton, S.J. Ventura, M.J. Osterman, S. Kirmeyer, T.J. Mathews, and et al. Births: final data for 2009 Natl Vital Stat Rep 60 2011 1 70
30. M.L. Wier, M. Pearl, and M. Kharrazi Gestational age estimation on United States livebirth certificates: a historical overview Paediatr Perinat Epidemiol 21 Suppl 2 2007 4 12
31. J. Challis, J. Newnham, F. Petraglia, M. Yeganegi, and A. Bocking Fetal sex and preterm birth Placenta 34 2013 95 99
32. C.V. Newburn-Cook, and J.E. Onyskiw Is older maternal age a risk factor for preterm birth and fetal growth restriction? A systematic review Health Care Women Int 26 2005 852 875
33. L.A. Schieve, M.E. Cogswell, K.S. Scanlon, G. Perry, C. Ferre, C. Blackmore-Prince, and et al. Prepregnancy body mass index and pregnancy weight gain: associations with preterm delivery. The NMIHS Collaborative Study Group Obstet Gynecol 96 2000 194 200
34. Z. Han, O. Lutsiv, S. Mulla, A. Rosen, J. Beyene, S.D. McDonald, and et al. Low gestational weight gain and the risk of preterm birth and low birthweight: a systematic review and meta-analyses Acta Obstet Gynecol Scand 90 2011 935 954
35. M. Olszanecka-Glinianowicz, P. Madej, A. Owczarek, J. Chudek, and P. Skalba Circulating anti-Mullerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome Clin Endocrinol (Oxf) 2014 Dec 1 10.1111/cen.12687 [Epub ahead of print]
36. R. Menon, M.R. Torloni, C. Voltolini, M. Torricelli, M. Merialdi, A.P. Betran, and et al. Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades Reprod Sci 18 2011 1046 1070
37. L.L. Jelliffe-Pawlowski, G.M. Shaw, R.J. Currier, D.K. Stevenson, R.J. Baer, H.M. O'Brodovich, and et al. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers Am J Obstet Gynecol 208 2013 492.e1 492.e11
38. A. Bachelot, and N. Binart Corpus luteum development: lessons from genetic models in mice Curr Top Dev Biol 68 2005 49 84
39. D.D. Baird The gestational timing of pregnancy loss: adaptive strategy? Am J Hum Biol 21 2009 725 727 10.1002/ajhb.20935
40. R. Romero, L. Yeo, P. Chaemsaithong, T. Chaiworapongsa, and S.S. Hassan Progesterone to prevent spontaneous preterm birth Semin Fetal Neonatal Med 19 2014 15 26
41. P.J. Meis, M. Klebanoff, E. Thom, M.P. Dombrowski, B. Sibai, A.H. Moawad, and et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385